CALL/QIAGEN/40.03/0.0999/20.12.24 Share Price

Warrant

DE000GZ697N0

Real-time BOERSE MUENCHEN 09:56:44 26/06/2024 pm IST
0.273 EUR -7.14% Intraday chart for CALL/QIAGEN/40.03/0.0999/20.12.24
Current month-20.75%
1 month-31.15%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
26/24/26 0.273 -7.14%
25/24/25 0.294 -6.07%
24/24/24 0.313 +2.96%
21/24/21 0.304 -0.65%
20/24/20 0.306 -3.16%

Real-time BOERSE MUENCHEN

Last update June 26, 2024 at 09:56 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying QIAGEN N.V.
Issuer Goldman Sachs
WKN GZ697N
ISINDE000GZ697N0
Date issued 28/12/2022
Strike 40.03
Maturity 20/12/2024 (177 Days)
Parity 10.01 : 1
Emission price 1.31
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.5
Lowest since issue 0.193
Delta0.49x
Omega 6.727
Premium12.17x
Gearing13.86x
Moneyness 0.9528
Difference Strike 1.89
Difference Strike %+4.72%
Spread 0.03
Spread %10.34%
Theoretical value 0.2730
Implied Volatility 30.70 %
Total Loss Probability 59.93 %
Intrinsic value 0.000000
Present value 0.2730
Break even 42.76 €
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Sector
-
More about the company

Ratings for Qiagen N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Qiagen N.V.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
41.04 USD
Average target price
50.39 USD
Spread / Average Target
+22.78%
Consensus